1. Home
  2. ASTI vs SNPX Comparison

ASTI vs SNPX Comparison

Compare ASTI & SNPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASTI
  • SNPX
  • Stock Information
  • Founded
  • ASTI 2005
  • SNPX 2012
  • Country
  • ASTI United States
  • SNPX United States
  • Employees
  • ASTI N/A
  • SNPX N/A
  • Industry
  • ASTI Semiconductors
  • SNPX Medicinal Chemicals and Botanical Products
  • Sector
  • ASTI Technology
  • SNPX Health Care
  • Exchange
  • ASTI Nasdaq
  • SNPX Nasdaq
  • Market Cap
  • ASTI 3.1M
  • SNPX 3.1M
  • IPO Year
  • ASTI N/A
  • SNPX N/A
  • Fundamental
  • Price
  • ASTI $1.68
  • SNPX $2.33
  • Analyst Decision
  • ASTI
  • SNPX Strong Buy
  • Analyst Count
  • ASTI 0
  • SNPX 1
  • Target Price
  • ASTI N/A
  • SNPX $14.00
  • AVG Volume (30 Days)
  • ASTI 53.6K
  • SNPX 11.5K
  • Earning Date
  • ASTI 05-08-2025
  • SNPX 05-14-2025
  • Dividend Yield
  • ASTI N/A
  • SNPX N/A
  • EPS Growth
  • ASTI N/A
  • SNPX N/A
  • EPS
  • ASTI N/A
  • SNPX N/A
  • Revenue
  • ASTI $41,893.00
  • SNPX N/A
  • Revenue This Year
  • ASTI N/A
  • SNPX N/A
  • Revenue Next Year
  • ASTI N/A
  • SNPX N/A
  • P/E Ratio
  • ASTI N/A
  • SNPX N/A
  • Revenue Growth
  • ASTI N/A
  • SNPX N/A
  • 52 Week Low
  • ASTI $1.17
  • SNPX $1.84
  • 52 Week High
  • ASTI $34.00
  • SNPX $5.38
  • Technical
  • Relative Strength Index (RSI)
  • ASTI 58.20
  • SNPX 49.26
  • Support Level
  • ASTI $1.30
  • SNPX $2.05
  • Resistance Level
  • ASTI $1.70
  • SNPX $2.21
  • Average True Range (ATR)
  • ASTI 0.13
  • SNPX 0.18
  • MACD
  • ASTI 0.06
  • SNPX 0.04
  • Stochastic Oscillator
  • ASTI 96.23
  • SNPX 79.51

About ASTI Ascent Solar Technologies Inc.

Ascent Solar Technologies Inc is engaged in the manufacturing and selling of photovoltaic products (PV) solar modules that are flexible, durable, and possess attractive power-to-weight and power-to-area performance. The company is integrating its PV products into scalable and high-value markets such as agrivoltaics, aerospace, satellites, near-earth orbiting vehicles, and fixed-wing unmanned aerial vehicles (UAV). Ascent is also working to expand its portable solar chargers, such as the XD-12. The company markets and sells its products through OEMs, system integrators, distributors, retailers, and e-commerce companies.

About SNPX Synaptogenix Inc.

Synaptogenix Inc is a biopharmaceutical company with product candidates in pre-clinical and clinical development. It is principally focused on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease, which is in the clinical testing stage. It is also evaluating bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X syndrome, Multiple Sclerosis, and Niemann-Pick Type C disease, which have undergone pre-clinical testing.

Share on Social Networks: